MUMBAI, India , November 2, 2022 (press release) –
India Medtronic Private Limited, a wholly owned subsidiary of
Some of the commonly seen IUA includes fibroids, polyps, retained products of conception, adhesions, malignancies, or hyperplasia.One of the symptoms of IUA is abnormal uterine bleeding (AUB). AUB refers to any vaginal bleeding that is unrelated to the normal menstrual cycle, that may manifest in the form of small amounts of spotting in between periods, or unusually heavy periods.
AUB is reported to occur in 9-14% women between menarche and menopause. The prevalence varies in each country. In
1 Watchful waiting and removal of the uterus (called a hysterectomy) are two common treatments to AUB. Between these two extremes is hysteroscopy, a minimally invasive treatment and the gold standard for allowing surgeons to look directly into the uterus and determine if AUB is related to fibroids, polyps, retained products of conceptions, or intrauterine adhesions.2 It does not requires incisions or electric shocks, and provides patients with a quicker recovery.
“TruClear system is a new addition to our GYN and women’s health portfolio and by introducing innovations like these we’re bringing choice, control and confidence to women’s healthcare in
TruClear™ is a next-generation device that provides practitioners with a clear operative field and patients with gentle mechanical resection during procedure to help efficiently execute a hysteroscopy. Unlike other intrauterine abnormality treatment options that use a high-frequency electric current, the TruClear™ system uses a simple mechanical approach to remove intrauterine tissue. Therefore, there is no scarring of the uterine lining from thermal energy or electrical energy, thus providing more hope of preserving the uterus for the future.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic.
1. https://www.nhp.gov.in/disease/gynaecology-and-obstetrics/abnormal-uterine-bleeding
2.
Click here for Media Contact Details
Submit your press release
The views expressed in content distributed by Newstex and its re-distributors (collectively, "Newstex Authoritative Content") are solely those of the respective author(s) and not necessarily the views of Newstex et al. It is provided as general information only on an "AS IS" basis, without warranties and conferring no rights, which should not be relied upon as professional advice. Newstex et al. make no claims, promises or guarantees regarding its accuracy or completeness, nor as to the quality of the opinions and commentary contained therein.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistribute or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.